Cargando…
Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer
Advanced castrate-resistant prostate cancer (CRPC) is a poorly prognostic disease currently lacking effective cure. Understanding the molecular mechanism that underlies the initiation and progression of CRPC will provide new strategies for treating this deadly disease. One candidate target is the fi...
Autores principales: | Wang, Cong, Liu, Ziying, Ke, Yuepeng, Wang, Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363687/ https://www.ncbi.nlm.nih.gov/pubmed/30761180 http://dx.doi.org/10.3389/fgene.2019.00012 |
Ejemplares similares
-
FGFR1 and WT1 are markers of human prostate cancer progression
por: Devilard, Elizabeth, et al.
Publicado: (2006) -
Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling
por: Nita, Alexandru, et al.
Publicado: (2021) -
CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1
por: Zhang, Ruirui, et al.
Publicado: (2021) -
Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment
por: Ko, Juyeon, et al.
Publicado: (2021) -
FGFR1, a novel biomarker for metastatic castration-resistant prostate cancer?
por: Gallo, Leandro H.
Publicado: (2021)